Rahul Sharma (Editor)

ATC code M05

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit

ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M05 is part of the anatomical group M Musculo-skeletal system.

Contents

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM05.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M05BA Bisphosphonates

M05BA01 Etidronic acid M05BA02 Clodronic acid M05BA03 Pamidronic acid M05BA04 Alendronic acid M05BA05 Tiludronic acid M05BA06 Ibandronic acid M05BA07 Risedronic acid M05BA08 Zoledronic acid

M05BB Bisphosphonates, combinations

M05BB01 Etidronic acid and calcium, sequential M05BB02 Risedronic acid and calcium, sequential M05BB03 Alendronic acid and colecalciferol M05BB04 Risedronic acid, calcium and colecalciferol, sequential M05BB05 Alendronic acid, calcium and colecalciferol, sequential M05BB06 Alendronic acid and alfacalcidol, sequential M05BB07 Risedronic acid and colecalciferol M05BB08 Zoledronic acid, calcium and colecalciferol, sequential

M05BC Bone morphogenetic proteins

M05BC01 Dibotermin alfa M05BC02 Eptotermin alfa

M05BX Other drugs affecting bone structure and mineralization

M05BX01 Ipriflavone M05BX02 Aluminium chlorohydrate M05BX03 Strontium ranelate M05BX04 Denosumab M05BX05 Burosumab M05BX53 Strontium ranelate and colecalciferol

References

ATC code M05 Wikipedia